tetano
Editor, Senior Moderator
Cells
. 2021 Nov 23;10(12):3279.
doi: 10.3390/cells10123279.
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells
Dante Barreda[SUP] 1 [/SUP], César Santiago[SUP] 2 [/SUP], Juan R Rodríguez[SUP] 3 [/SUP], José F Rodríguez[SUP] 3 [/SUP], José M Casasnovas[SUP] 2 [/SUP], Isabel Mérida[SUP] 1 [/SUP], Antonia Ávila-Flores[SUP] 1 [/SUP]
Affiliations
Abstract
Dendritic cells (DCs) are the most potent antigen-presenting cells, and their function is essential to configure adaptative immunity and avoid excessive inflammation. DCs are predicted to play a crucial role in the clinical evolution of the infection by the severe acute respiratory syndrome (SARS) coronavirus (CoV)-2. DCs interaction with the SARS-CoV-2 Spike protein, which mediates cell receptor binding and subsequent fusion of the viral particle with host cell, is a key step to induce effective immunity against this virus and in the S protein-based vaccination protocols. Here we evaluated human DCs in response to SARS-CoV-2 S protein, or to a fragment encompassing the receptor binding domain (RBD) challenge. Both proteins increased the expression of maturation markers, including MHC molecules and costimulatory receptors. DCs interaction with the SARS-CoV-2 S protein promotes activation of key signaling molecules involved in inflammation, including MAPK, AKT, STAT1, and NFκB, which correlates with the expression and secretion of distinctive proinflammatory cytokines. Differences in the expression of ACE2 along the differentiation of human monocytes to mature DCs and inter-donor were found. Our results show that SARS-CoV-2 S protein promotes inflammatory response and provides molecular links between individual variations and the degree of response against this virus.
Keywords: ACE-2; COVID-19; cytokines; inflammation.
. 2021 Nov 23;10(12):3279.
doi: 10.3390/cells10123279.
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells
Dante Barreda[SUP] 1 [/SUP], César Santiago[SUP] 2 [/SUP], Juan R Rodríguez[SUP] 3 [/SUP], José F Rodríguez[SUP] 3 [/SUP], José M Casasnovas[SUP] 2 [/SUP], Isabel Mérida[SUP] 1 [/SUP], Antonia Ávila-Flores[SUP] 1 [/SUP]
Affiliations
- PMID: 34943787
- DOI: 10.3390/cells10123279
Abstract
Dendritic cells (DCs) are the most potent antigen-presenting cells, and their function is essential to configure adaptative immunity and avoid excessive inflammation. DCs are predicted to play a crucial role in the clinical evolution of the infection by the severe acute respiratory syndrome (SARS) coronavirus (CoV)-2. DCs interaction with the SARS-CoV-2 Spike protein, which mediates cell receptor binding and subsequent fusion of the viral particle with host cell, is a key step to induce effective immunity against this virus and in the S protein-based vaccination protocols. Here we evaluated human DCs in response to SARS-CoV-2 S protein, or to a fragment encompassing the receptor binding domain (RBD) challenge. Both proteins increased the expression of maturation markers, including MHC molecules and costimulatory receptors. DCs interaction with the SARS-CoV-2 S protein promotes activation of key signaling molecules involved in inflammation, including MAPK, AKT, STAT1, and NFκB, which correlates with the expression and secretion of distinctive proinflammatory cytokines. Differences in the expression of ACE2 along the differentiation of human monocytes to mature DCs and inter-donor were found. Our results show that SARS-CoV-2 S protein promotes inflammatory response and provides molecular links between individual variations and the degree of response against this virus.
Keywords: ACE-2; COVID-19; cytokines; inflammation.